Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2025 ,inter alia, to consider and approve proposal for raising of funds by way of issue of securities through further public offer, rights issue, American Depository Receipts/ Global Depository Receipts/ Foreign Currency Convertible Bonds, qualified institutions placement, debt issue, preferential issue or any other method as may be decided and considered appropriate, subject to such regulatory/statutory approvals as may be required, and matters related and incidental thereto.